glp 1 agonists and anesthesia Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 GLP-1 medications safe to continue
Description
Continuous stimulation of dual-function peptide PGLP-1-VP inhibits the morbidity and mortality of NOD mice through anti-inflammation and immunoregulation
Fundamental body composition principles provide context for fat-free and skeletal muscle loss with GLP-1 RA treatments
The influence of diabetes in the pathogenesis and the clinical course of hepatocellular carcinoma: Recent findings and new perspectives
Richards et al., 2014)
Excess weight loss (EWL) of at least 50% and remission of comorbidities are considered a success post MBS
Review: GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits
